Posted by ABMN Staff on May 11th, 2024
Curis, Inc. (NASDAQ:CRIS – Free Report) – HC Wainwright lifted their Q2 2024 earnings estimates for Curis in a note issued to investors on Wednesday, May 8th. HC Wainwright analyst E. White now forecasts that the biotechnology...
More of this article »